Covington Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.73M | Buy |
14,630
+140
| +1% | +$44.4K | 0.2% | 123 |
|
|
2022
Q2 | $4.7M | Buy |
14,490
+1,931
| +15% | +$580K | 0.19% | 129 |
|
|
2022
Q1 | $3.6M | Buy |
12,559
+4,702
| +60% | +$1.21M | 0.13% | 153 |
|
|
2021
Q4 | $2.17M | Buy |
7,857
+18
| +0.2% | +$4.56K | 0.07% | 181 |
|
|
2021
Q3 | $1.81M | Buy |
7,839
+40
| +0.5% | +$9.87K | 0.07% | 191 |
|
|
2021
Q2 | $1.79M | Buy |
7,799
+767
| +11% | +$154K | 0.07% | 193 |
|
|
2021
Q1 | $1.31M | Sell |
7,032
-142
| -2% | -$27.8K | 0.06% | 203 |
|
|
2020
Q4 | $1.21M | Buy |
7,174
+89
| +1% | +$13.3K | 0.05% | 196 |
|
|
2020
Q3 | $1.05M | Buy |
7,085
+50
| +0.7% | +$7.74K | 0.05% | 199 |
|
|
2020
Q2 | $1.16M | Sell |
7,035
-32
| -0.5% | -$4.91K | 0.06% | 184 |
|
|
2020
Q1 | $980K | Buy |
7,067
+140
| +2% | +$19.2K | 0.06% | 183 |
|
|
2019
Q4 | $910K | Buy |
6,927
+143
| +2% | +$16.6K | 0.05% | 203 |
|
|
2019
Q3 | $759K | Sell |
6,784
-2,616
| -28% | -$291K | 0.04% | 202 |
|
|
2019
Q2 | $1.04M | Hold |
9,400
| – | – | 0.06% | 178 |
|
|
2019
Q1 | $1.22M | Hold |
9,400
| – | – | 0.08% | 169 |
|
|
2018
Q4 | $1.09M | Buy |
9,400
+600
| +7% | +$67K | 0.08% | 168 |
|
|
2018
Q3 | $944K | Sell |
8,800
-6,975
| -44% | -$697K | 0.06% | 185 |
|
|
2018
Q2 | $1.35M | Buy |
15,775
+25
| +0.2% | +$2.05K | 0.09% | 165 |
|
|
2018
Q1 | $1.22M | Sell |
15,750
-4,025
| -20% | -$324K | 0.08% | 167 |
|
|
2017
Q4 | $1.67M | Sell |
19,775
-50
| -0.3% | -$4.25K | 0.1% | 148 |
|
|
2017
Q3 | $1.7M | Buy |
19,825
+4,625
| +30% | +$379K | 0.11% | 144 |
|
|
2017
Q2 | $1.25M | Hold |
15,200
| – | – | 0.1% | 141 |
|
|
2017
Q1 | $1.28M | Sell |
15,200
-45
| -0.3% | -$3.6K | 0.11% | 139 |
|
|
2016
Q4 | $1.12M | Hold |
15,245
| – | – | 0.1% | 141 |
|
|
2016
Q3 | $1.22M | Sell |
15,245
-100
| -0.7% | -$8K | 0.11% | 132 |
|
|
2016
Q2 | $1.21M | Buy |
15,345
+91
| +0.6% | +$6.85K | 0.11% | 137 |
|
|
2016
Q1 | $1.1M | Sell |
15,254
-81
| -0.5% | -$6.13K | 0.11% | 141 |
|
|
2015
Q4 | $1.29M | Sell |
15,335
-115
| -0.7% | -$9.54K | 0.13% | 127 |
|
|
2015
Q3 | $1.29M | Buy |
15,450
+1,650
| +12% | +$139K | 0.13% | 130 |
|
|
2015
Q2 | $1.15M | Hold |
13,800
| – | – | 0.1% | 145 |
|
|
2015
Q1 | $1M | Buy |
13,800
+500
| +4% | +$35.6K | 0.1% | 135 |
|
|
2014
Q4 | $918K | Hold |
13,300
| – | – | 0.08% | 158 |
|
|
2014
Q3 | $863K | Hold |
13,300
| – | – | 0.08% | 166 |
|
|
2014
Q2 | $839K | Sell |
13,300
-100
| -0.7% | -$5.97K | 0.08% | 164 |
|
|
2014
Q1 | $789K | Sell |
13,400
-775
| -5% | -$43.3K | 0.08% | 161 |
|
|
2013
Q4 | $723K | Hold |
14,175
| – | – | 0.07% | 160 |
|
|
2013
Q3 | $713K | Buy |
14,175
+275
| +2% | +$14.4K | 0.08% | 149 |
|
|
2013
Q2 | $683K | Buy |
+13,900
| New | +$756K | 0.08% | 153 |
|
Other funds holding LLY
Covington Capital Management's LLY Position: Q3 2022 in Review
Covington Capital Management increased its Eli Lilly (LLY) stake by 0.97% in Q3 2022, buying an estimated $44.4K and bringing the position to 14,630 shares worth $4.73M. The position accounts for 0.2% of the portfolio, ranked #123.
Covington Capital Management first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Covington Capital Management held 14,630 shares of Eli Lilly worth $4.73M as of Q3 2022.
- Covington Capital Management bought 140 Eli Lilly shares in Q3 2022, an estimated $44.4K.
- Eli Lilly made up 0.2% of Covington Capital Management's portfolio in Q3 2022, its #123 holding.
- Covington Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- 2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.